N-terminal HIV-1 Tat nonapeptides as inhibitors of dipeptidyl peptidase IV. Conformational characterization
- PMID: 10849738
- DOI: 10.1007/0-306-46826-3_13
N-terminal HIV-1 Tat nonapeptides as inhibitors of dipeptidyl peptidase IV. Conformational characterization
Abstract
Compared to the N-terminal nonapeptide of the HIV-1 Tat protein as inhibitor of activity of DP IV which is supposed to mediate the immunosuppressive effects of HIV-1 Tat, the Ile5 and Leu6 analogues showed strongly reduced inhibitory activity. Interestingly, replacement of Asp2 with Gly or Lys led to compounds with considerably enhanced inhibition. Therefore, we have applied 1H NMR spectroscopy and restrained molecular dynamics calculations to elucidate the molecular conformation of a series of Tat nonapeptides. Conformational backbone differences of these peptides as well as the nature and the arrangement of the side chains per se at significant positions preventing effective binding to DP IV might explain their different inhibitory activity on DP IV.
Similar articles
-
Effects of nonapeptides derived from the N-terminal structure of human immunodeficiency virus-1 (HIV-1) Tat on suppression of CD26-dependent T cell growth.Adv Exp Med Biol. 2000;477:161-5. doi: 10.1007/0-306-46826-3_18. Adv Exp Med Biol. 2000. PMID: 10849743
-
The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth.J Biol Chem. 1997 Nov 28;272(48):30283-8. doi: 10.1074/jbc.272.48.30283. J Biol Chem. 1997. PMID: 9374514
-
1H NMR conformational study on N-terminal nonapeptide sequences of HIV-1 Tat protein: a contribution to structure-activity relationships.J Pept Sci. 1998 Sep;4(6):400-10. doi: 10.1002/(sici)1099-1387(199809)4:6<400::aid-psc162>3.0.co;2-g. J Pept Sci. 1998. PMID: 9796859
-
Molecular mechanism and structural basis of interactions of dipeptidyl peptidase IV with adenosine deaminase and human immunodeficiency virus type-1 transcription transactivator.Eur J Cell Biol. 2012 Apr;91(4):265-73. doi: 10.1016/j.ejcb.2011.06.001. Epub 2011 Sep 28. Eur J Cell Biol. 2012. PMID: 21856036 Review.
-
How Tat targets TAR: structure of the BIV peptide-RNA complex.Structure. 1996 Jan 15;4(1):5-9. doi: 10.1016/S0969-2126(96)00003-2. Structure. 1996. PMID: 8805518 Review.
Cited by
-
Blood Sampling From Rat Ileal Mesenteric Vein Revealed a Major Role of Dietary Protein in Meal-Induced GLP-1 Response.Front Endocrinol (Lausanne). 2021 Jun 2;12:689685. doi: 10.3389/fendo.2021.689685. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34149624 Free PMC article.
-
Daily supplementation of dietary protein improves the metabolic effects of GLP-1-based pharmacotherapy in lean and obese rats.Physiol Behav. 2017 Aug 1;177:122-128. doi: 10.1016/j.physbeh.2017.04.017. Epub 2017 Apr 19. Physiol Behav. 2017. PMID: 28433470 Free PMC article.
-
Intraduodenal milk protein concentrate augments the glycemic and food intake suppressive effects of DPP-IV inhibition.Am J Physiol Regul Integr Comp Physiol. 2014 Feb 1;306(3):R157-63. doi: 10.1152/ajpregu.00358.2013. Epub 2013 Dec 18. Am J Physiol Regul Integr Comp Physiol. 2014. PMID: 24352410 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
